FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
16/07/2026
Voltar para busca
Dado oficial do USPTO
SELECTAILOR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SELECTAILOR
ST13
US500000079410858Classe
35, 40, 42
Pedido
79410858
Registro
8064049
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
25
Atualização mais recente
16/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 40, 42
Data de depósito
05/09/2024
Data de registro
16/12/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/12/2025
Última transação
16/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
KR
Examinador
CROSS, TRACY L
Unidade examinadora
L90
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Samsung Biologics Co., Ltd.
Representantes
Brian P. Gregg McNees Wallace & Nurick
Classificação técnica
Classes Nice
Classe 35Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Advertising and commercial information services; business administration and office work; marketing services; demonstration of goods; import-export agency services; business advice for companies relating to medical services and healthcare; collection of electronic data for business purposes in the field of medicine and healthcare; on-line wholesale store services featuring pharmaceuticals; on-line retail store services featuring pharmaceuticals; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; Promoting the goods of others by providing a website featuring product information in the field of pharmaceuticals; providing consumer product information via the Internet; promoting the goods and services by means of operating an on-line comprehensive shopping mall with links to the retail web sites of others; electronic data processing services relating to health care information; accountancy advice; health care cost management consultation; statistical analysisdata evaluation and preparation of business reports relating thereto in the field of healthcare.
Classe 40
Custom manufacture of biopharmaceuticals; processing of medicinal materials; custom manufacture of pharmaceuticals; preservation of pharmaceuticals; processing of pharmaceuticals; processing of chemicals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; chemical treatment of liquids; custom manufacture of cell lines for biopharmaceutical manufacturing; custom manufacture of specific antibody-binding glycosylated drugs.
Classe 42
Conducting early evaluations in the field of new pharmaceuticals; drug discovery services; pharmaceutical research and development; research of pharmaceuticals; pharmaceutical product evaluation; toxicity analysis for research purposes; scientific research in the nature of conducting clinical trials for others; clinical research in the field of medicine; testing services for assessing the efficiency of pharmaceuticals; analysis and evaluation of medical product development; medical research laboratories; providing information on the testinginspection and research of medical products; medicine research; providing medical and scientific research information in the field of clinical trial progress; computer programming in the medical field; scientific research in the field of multiple nucleic acid analysis; scientific research in the field of protein analysis; biotechnology research; scientific research in the field of genetics; scientific research; scientific research in the field of molecular analysis; scientific research in the field of food; development of biotechnology; scientific research in the field of biochemical analysis; scientific research in the field of genetics and genetic engineering; biochemical research; culturing of cells for scientific research purposes; scientific research in the field of biological analysis; biochemical research; scientific research of biologics; development of pharmaceutical preparations and medicines; science laboratory services for high-efficiency glycan analysis; biological research and analysis relating to glycosylation profiles; computer software technical support service relating to troubleshooting and management support of medical image data.
Publicações
Histórico de despachos e eventos da marca no USPTO.
25 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
30/06/2026
FIMP
FINAL DISPOSITION PROCESSED
30/06/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
14/05/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/04/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27/04/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
16/03/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
16/12/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
16/12/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/10/2025
PUBO
PUBLISHED FOR OPPOSITION
28/10/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/10/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/09/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/09/2025
RFNT
REFUSAL PROCESSED BY IB
09/05/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/04/2025
RFRR
REFUSAL PROCESSED BY MPU
18/04/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/03/2025
CNRT
NON-FINAL ACTION WRITTEN
11/03/2025
DOCK
ASSIGNED TO EXAMINER
07/03/2025
MAFR
APPLICATION FILING RECEIPT MAILED
02/12/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/12/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/11/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SELECTAILOR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.